Drug Trial Radar · NCT00003782
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Last checked: Nov 19, 2026Latest source record: Mar 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,351
Actual
Start
Mar 1999
Primary completion
Dec 2008
Study completion Dec 2012
Sponsor
- Lead sponsor
- NSABP Foundation IncResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving combination chemotherapy after surgery may kill any tumor cells remaining following surgery. It is not yet known which regimen of combination chemotherapy is more effective in treating breast cancer with positive axillary lymph nodes. PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy in treating women who have undergone surgery for stage I, stage II, or stage IIIA breast cancer with positive axillary lymph nodes.
Conditions
- Breast Cancer
Interventions
cyclophosphamideDrug
Arm 1: 600 mg/m2 IV every 21 days for 4 cycles; Arm 3: 500 mg/m2 IV every 21 days for 4 cycles
docetaxelDrug
Arm 1: 100 mg/m2 IV every 21 days for 4 cycles; Arms 2 and 3: 75 mg/m2 IV every 21 days for 4 cycles
doxorubicinDrug
Arm 1: 60 mg/m2 IV every 21 days for 4 cycles; Arms 2 and 3: 50 mg/m2 IV every 21 days for 4 cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: 8 years
- Disease Free SurvivalTime frame: time to event: breast cancer recurrence; second primary cancer; death from any cause as a first event
Locations
157 sites in 2 countries. Site status is shown where the registry gives one.
Comprehensive Cancer Institute
Huntsville, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
CCOP - Western Regional, Arizona
Phoenix, Arizona
City of Hope Comprehensive Cancer Center
Duarte, California
California Cancer Center
Fresno, California
Sutter Health Western Division Cancer Research Group
Greenbrae, California
Scripps Cancer Center at Scripps Clinic
La Jolla, California
Rebecca and John Moores UCSD Cancer Center
La Jolla, California
Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California
Pacific Shores Medical Group
Long Beach, California
CCOP - Bay Area Tumor Institute
Oakland, California
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
Orange, California
Comprehensive Cancer Centers of the Desert
Palm Springs, California
Stanford Cancer Center at Stanford University Medical Center
Palo Alto, California
Sutter Cancer Center
Sacramento, California
Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego
San Diego, California
Catholic Healthcare West - Westbay Region
San Francisco, California
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California
Kaiser Permanente Medical Center - Vallejo
Vallejo, California
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado
CCOP - Colorado Cancer Research Program, Incorporated
Denver, Colorado
University of Connecticut Cancer Center at University of Connecticut Health Center
Farmington, Connecticut
Hartford Hospital
Hartford, Connecticut
CCOP - Christiana Care Health Services
Wilmington, Delaware
MBCCOP - Howard University Cancer Center
Washington D.C., District of Columbia
Morton Plant Hospital
Clearwater, Florida
Halifax Medical Center
Daytona Beach, Florida
Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida
University of Miami Sylvester Cancer Center
Miami, Florida
CCOP - Mount Sinai Medical Center
Miami Beach, Florida
MD Anderson Cancer Center Orlando
Orlando, Florida
Sarasota Memorial Hospital
Sarasota, Florida
Winship Cancer Institute of Emory University
Atlanta, Georgia
CCOP - Atlanta Regional
Atlanta, Georgia
Medical College of Georgia Comprehensive Cancer Center
Augusta, Georgia
Dwight David Eisenhower Army Medical Center
Fort Gordon, Georgia
Cancer Research Center of Hawaii
Honolulu, Hawaii
North Idaho Cancer Center
Coeur d'Alene, Idaho
John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois
Showing 40 of 157 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.